Author(s): BarShira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, , BarShira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR,
Abstract Share this page
Abstract We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.
This article was published in Cancer Res
and referenced in Journal of Cancer Science & Therapy